nach oben

Zeitschrift für Gerontologie und Geriatrie

Erschienen in:

10.08.2021 | Original Contributions

Nonmotor symptoms and quality of life in Parkinson’s disease with different motor subtypes

verfasst von: Dong-Dong Wu, MD, Wen Su, MD, Jing He, MD, Shu-Hua Li, MD, Kai Li, MD, Hai-Bo Chen, MD

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

To explore the differences in the features and impact on quality of life (QOL) of nonmotor symptoms (NMS) of the tremor dominant (TD) and non-tremor dominant (NTD) subtypes of Parkinson’s disease (PD) and elucidate the characteristic NMS and determinants of QOL for the subtypes.

Methods

This cross-sectional study included 77 patients with PD. The NMS questionnaire was used to assess the range and prevalence of NMS. The modified Hoehn and Yahr staging and the unified PD rating scale (UPDRS) were used to assess symptom severity. Cognitive abilities were investigated using the mini-mental status examination (MMSE). Emotional state was assessed using the Hamilton depression scale (HAMD) and the Hamilton anxiety scale (HAMA) and QOL was evaluated using the Parkinson’s disease questionnaire-39 (PDQ-39).

Results

Overall, 39 (50.65%) patients were classified as the TD subtype, and 38 (49.35%) were classified as the NTD subtype. Patients with NTD subtype presented a significantly higher number of NMS total scores (P = 0.007) and significantly higher score in the cognition domain of PDQ-39 (P = 0.021) than patients with TD subtype. Patients with NTD subtype had significantly higher NMS prevalence than patients with TD subtype with constipation (P = 0.021), incomplete bowel emptying (P = 0.050), anxiety (P = 0.030), daytime sleepiness (P = 0.017) and intense vivid dreams (P = 0.016). The predictors for the NTD subtype were intense vivid dreams (P = 0.012), anxiety (P = 0.030) and constipation (P = 0.044). The UPDRS, NMS total, and MMSE scores were the determinants of QOL in patients with PD (P < 0.05).

Conclusion

The NMS is a prominent manifestation of PD. Patients with the NTD subtype had a higher prevalence of NMS than those with the TD subtype and intense vivid dreams, anxiety and constipation were characteristic of the NTD subtype. NMS is one of the important factors that determine the QOL of patients with PD especially those with the NTD subtype.

Vorheriger Artikel Rückenschmerz: ein Phänomen des Alters?

Nächster Artikel Exergames zur Förderung der körperlichen Aktivität und Mobilität in der stationären Langzeitpflege – Ein Überblick

Nur mit Berechtigung zugänglich

Duncan GW, Khoo TK, Yarnall AJ et al (2014) Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord 29(2):195–202. https://doi.org/10.1002/mds.25664CrossRefPubMed

Zis P, Martinez-Martin P, Sauerbier A et al (2015) Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol 22(8):1145–1150. https://doi.org/10.1111/ene.12733CrossRefPubMed

Zis P, Rizos A, Martinez-Martin P et al (2014) Non motor symptoms profile and burden in drug naive versus long-term Parkinson’s disease patients. J Parkinsons Dis 4(3):541–547. https://doi.org/10.3233/JPD-140372CrossRefPubMed

Jellinger KA (2015) Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm (Vienna) 122(10):1429–1440CrossRef

Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DAT ATOP cohort. Neurology 40(10):1529CrossRef

Reinoso G, Allen JC Jr, Au WL et al (2015) Clinical evolution of Parkinson’s disease and prognostic factors affecting motor progression: 9‑year follow up study. Eur J Neurol 22(3):457–463. https://doi.org/10.1111/ene.12476CrossRefPubMed

van de Berg WD, Hepp DH, Dijkstra AA et al (2012) Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson’s disease. Parkinsonism Relat Disord 18:S28–S30CrossRef

Burn DJ, Landau S, Hindle JV et al (2012) Parkinson’s disease motor subtypes and mood. Mov Disord 27(3):379–386. https://doi.org/10.1002/mds.24041CrossRefPubMed

Brown RG, Landau S, Hindle JV et al (2011) Depression and anxiety related subtypes in Parkinson’s disease. J Neurol Neurosurg Psychiatry 82(7):803–809. https://doi.org/10.1136/jnnp.2010.213652CrossRefPubMed

10.

Khoo TK, Yarnall AJ, Duncan GW et al (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276–281CrossRef

11.

Postama RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. https://doi.org/10.1002/mds.26424CrossRef

12.

Selikhova M, Williams DR, Kempster PA et al (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132(11):2947–2957. https://doi.org/10.1093/brain/awp234CrossRefPubMed

13.

Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006) International multicenter pilot study of the first comprehensive self completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923CrossRef

14.

Chaudhuri KR, Healy DG, Schapira AHV (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245CrossRef

15.

Azmin S, Khairul Anuar AM, Tan HJ et al (2014) Nonmotor symptoms in a malaysian Parkinson’s disease population. Parkinsons Dis 2014:472157PubMedPubMedCentral

16.

Edwards L, Quigley EM, Hofman R et al (1993) Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord 8:83–86CrossRef

17.

Kim HJ, Park SY, Cho YJ et al (2009) Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 287:200–204CrossRef

18.

Bronner G, Cohen OS, Yahalom G et al (2014) Correlates of quality of sexual life in male and female patients with Parkinson disease and their partners. Parkinsonism Relat Disord 20(10):1085–1088. https://doi.org/10.1016/j.Parkreldis.2014.07.003CrossRefPubMed

19.

Bohnen NI, Frey KA, Studenski S et al (2013) Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology 81(18):1611–1616CrossRef

20.

Rajput AH, Sitte HH, Rajput A et al (2008) Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70:1403–1410CrossRef

21.

Selikhova M, Kempster PA, Revesz T et al (2013) Neuropathological findings in benign tremulous Parkinsonism. Mov Disord 28:145–152CrossRef

22.

Schiess MC, Zheng H, Soukup VM et al (2000) Parkinson’s disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. Parkinsonism Relat Disord 6:69–76CrossRef

23.

Saiki S, Hirose G, Sakai K et al (2004) Cardiac ¹²³I‑MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 220:105–111CrossRef

24.

Spiegel J, Hellwig D, Farmakis G et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord 22:1004–1008CrossRef

25.

Nausieda PA, Glantz R, Weber S et al (1984) Psychiatric complications of levodopa therapy of Parkinson’s disease. Adv Neurol 40:271–277PubMed

26.

Pappert EJ, Goetz CG, Niederman FG et al (1999) Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s disease. Mov Disord 14:117–121CrossRef

27.

Arnulf I, Bonnet AM, Damier P et al (2000) Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology 55:281–288CrossRef

28.

Diederich NJ, Goetz CG, Stebbins GT (2005) Repeated visual hallucinations in Parkinson’s disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 20:130–140CrossRef

29.

Gibson G, Mottram PG, Burn DJ et al (2013) Frequency, prevalence, incidence and risk factors associated with hallucinations in a sample of patients with Parkinson’s disease: a longitudinal 4‑year study. Int J Geriatr Psychiatry 28(6):626–631CrossRef

30.

Svetel M, Smiljković T, Pekmezović T et al (2012) Hallucinations in Parkinson’s disease: cross-sectional study. Acta Neurol Belg 112(1):33–37CrossRef

31.

Hobson JA, Pace-Schott EF (2002) The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 3:679–693CrossRef

32.

Steriade M, Pare D, Bouhassira D et al (1989) Phasic activation of lateral geniculate and perigeniculate thalamic neurons during sleep with ponto-geniculo-occipital waves. J Neurosci 9:2215–2229CrossRef

33.

Broen MP, Narayen NE, Kuijf ML et al (2016) Prevalence of anxiety in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 31:1125–1133CrossRef

34.

Walsh K, Bennett G (2001) Parkinson’s disease and anxiety. Postgrad Med J 77:89–93CrossRef

35.

Ray S, Agarwal P (2020) Depression and anxiety in Parkinson disease. Clin Geriatr Med 36(1):93–104CrossRef

36.

Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 2(2):107–116CrossRef

37.

Edwards LL, Quigley EM, Harned RK et al (1994) Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol 89(1):15–25PubMed

38.

Muller B, Larsen JP, Wentzel-Larsen T et al (2011) Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s disease: frequent but mild. Mov Disord 26:65–72CrossRef

39.

Song W, Guo X, Chen K et al (2014) The impact of non-motor symptoms on the health-related quality of life of Parkinson’s disease patients from southwest China. Parkinsonism Relat Disord 20:149–152CrossRef

40.

Hariz GM, Forsgren L (2011) Activities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls. Acta Neurol Scand 123:20–27CrossRef

Titel: Nonmotor symptoms and quality of life in Parkinson’s disease with different motor subtypes
verfasst von: Dong-Dong Wu, MD
Wen Su, MD
Jing He, MD
Shu-Hua Li, MD
Kai Li, MD
Hai-Bo Chen, MD
Publikationsdatum: 10.08.2021
Verlag: Springer Medizin
Erschienen in: Zeitschrift für Gerontologie und Geriatrie / Ausgabe 6/2022
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI: https://doi.org/10.1007/s00391-021-01950-3

Springerpflege

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2022

Mitteilungen des BV Geriatrie

Exergames zur Förderung der körperlichen Aktivität und Mobilität in der stationären Langzeitpflege – Ein Überblick

Kardiologie im Alter

Antirheumatic drugs in older adults and polypharmacy issues

Pharmakologische Therapie kardiologischer Erkrankungen im Alter

Rückenschmerz: ein Phänomen des Alters?